These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21679836)

  • 1. Metastatic cutaneous squamous cell carcinoma responding to erlotinib therapy.
    Engelhardt C; Curiel-Lewandrowski C; Warneke J; Cranmer L
    J Am Acad Dermatol; 2011 Jul; 65(1):237-8. PubMed ID: 21679836
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study.
    Brantsch KD; Meisner C; Schönfisch B; Trilling B; Wehner-Caroli J; Röcken M; Breuninger H
    Lancet Oncol; 2008 Aug; 9(8):713-20. PubMed ID: 18617440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase 1 study of erlotinib plus radiation therapy in patients with advanced cutaneous squamous cell carcinoma.
    Heath CH; Deep NL; Nabell L; Carroll WR; Desmond R; Clemons L; Spencer S; Magnuson JS; Rosenthal EL
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1275-81. PubMed ID: 23182701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes and prognostic factors associated with the response to erlotinib in non-small-cell lung cancer patients with unknown EGFR mutational status.
    Aydiner A; Yildiz I; Seyidova A
    Asian Pac J Cancer Prev; 2013; 14(5):3255-61. PubMed ID: 23803112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Adjuvant Radiotherapy in the Treatment of High-risk Cutaneous Squamous Cell Carcinoma With Perineural Invasion.
    Stevenson ML; Criscito MC; Wilken R; Doudican NA; Bain EE; Parashar B; Carucci JA
    JAMA Dermatol; 2020 Aug; 156(8):918-921. PubMed ID: 32609298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent primary cutaneous primitive neuroectodermal tumor 4 years after chemotherapy.
    Morrison LK; Shamma HN; Heffernan MP
    J Am Acad Dermatol; 2011 Aug; 65(2):440-441. PubMed ID: 21763576
    [No Abstract]   [Full Text] [Related]  

  • 7. A prospective evaluation of the clinical, histologic, and therapeutic variables associated with incidental perineural invasion in cutaneous squamous cell carcinoma.
    Campoli M; Brodland DG; Zitelli J
    J Am Acad Dermatol; 2014 Apr; 70(4):630-636. PubMed ID: 24433872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic progression following complete cutaneous remission under bexarotene treatment for tumor-stage mycosis fungoides.
    Amitay-Laish I; David M; Hodak E
    J Am Acad Dermatol; 2009 Aug; 61(2):361-2. PubMed ID: 19615550
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical outcomes in high-risk squamous cell carcinoma patients treated with Mohs micrographic surgery alone.
    Marrazzo G; Zitelli JA; Brodland D
    J Am Acad Dermatol; 2019 Mar; 80(3):633-638. PubMed ID: 30244064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trichomegaly of the eyelashes after treatment with erlotinib in non-small cell lung cancer.
    Carser JE; Summers YJ
    J Thorac Oncol; 2006 Nov; 1(9):1040-1. PubMed ID: 17409992
    [No Abstract]   [Full Text] [Related]  

  • 11. Head and neck cutaneous squamous cell carcinoma requiring parotidectomy: prognostic indicators and treatment selection.
    Sweeny L; Zimmerman T; Carroll WR; Schmalbach CE; Day KE; Rosenthal EL
    Otolaryngol Head Neck Surg; 2014 Apr; 150(4):610-7. PubMed ID: 24474713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four times repeated isolated limb infusion with melphalan-controlled locoregional disease in the patient with melanoma of the leg.
    El Halabi H; Hijaz F; Gushchin V
    Am Surg; 2012 Dec; 78(12):E504-5. PubMed ID: 23265100
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prognostic influence of cutaneous involvement in malignant tumors of the oral cavity].
    Tankéré F; Camproux A; Barry B; Guedon C; Depondt J; Gehanno P
    Ann Otolaryngol Chir Cervicofac; 2000 Mar; 117(2):85-90. PubMed ID: 10739997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining, treating, and studying very high-risk cutaneous squamous cell carcinomas.
    Miller SJ
    Arch Dermatol; 2010 Nov; 146(11):1292-5. PubMed ID: 21079069
    [No Abstract]   [Full Text] [Related]  

  • 15. Time to rethink TNM staging in cutaneous SCC.
    Veness MJ
    Lancet Oncol; 2008 Aug; 9(8):702-3. PubMed ID: 18672208
    [No Abstract]   [Full Text] [Related]  

  • 16. Squamous cell carcinoma of the umbilicus: management of an unusual localization.
    Macripò G; Caliendo V; Grassi M; Lista P; Ribero S; Giacone E; Milanese E; Ciuffreda L
    Tumori; 2011; 97(2):236-8. PubMed ID: 21617723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Considerations for Completion Biopsy of Cutaneous Squamous Cell Carcinoma.
    Phillips CB
    Dermatol Surg; 2016 Aug; 42(8):1013-4. PubMed ID: 27261773
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of a giant squamous cell carcinoma on the dominant thumb with intralesional 5-fluorouracil.
    Reisinger DM; Cognetta AB; Pynes LT; Paredes AA; Sweeney TJ; Dolson DJ
    J Am Acad Dermatol; 2011 Jul; 65(1):219-21. PubMed ID: 21679825
    [No Abstract]   [Full Text] [Related]  

  • 19. Invasive squamous cell carcinoma of the skin: defining a high-risk group.
    Mullen JT; Feng L; Xing Y; Mansfield PF; Gershenwald JE; Lee JE; Ross MI; Cormier JN
    Ann Surg Oncol; 2006 Jul; 13(7):902-9. PubMed ID: 16788750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs micrographic surgery: A 5-year, multicenter, prospective cohort study.
    Tschetter AJ; Campoli MR; Zitelli JA; Brodland DG
    J Am Acad Dermatol; 2020 Jan; 82(1):139-148. PubMed ID: 31279037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.